Gennex Laboratories opened higher at ₹9.13, compared with its previous close of ₹9.04. In the last trading session on 12 Nov 2026, the stock traded between ₹9.05 and ₹9.30, with an average traded price of ₹9.22. It showed an upward intraday trend.
An investment of ₹10,000 made 5 years ago in Gennex Laboratories is now worth
₹ 12,962.00
Giving a profit of
₹ 2,962.00 (29.62%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+0.15 (+1.66%)
Day High
₹9.30
Day Low
₹9.05
Day Open
₹9.13
Prev Close
₹9.04
Volume
4,47,721
Value Traded
₹0.41 Cr
1W Return
-2.03%
1M Return
-4.37%
3M Return
3.37%
6M Return
-7.55%
1Y Return
-41.46%
Market Cap (₹ Cr.)
223
PE Ratio
10.60
PB Ratio
0.99
Dividend Yield
-
ROE
9.01%
ROCE
9.93%
Book Value (₹)
9.16
Face Value (₹)
1.00
EPS (TTM)
0.19
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-2.03%
6 Weeks
-
1 Month
-4.37%
3 Months
3.37%
9 Months
-26.13%
Gennex Laboratories passes all resolutions at 41st AGM
Gennex Laboratories held its 41st electronic AGM on September 30, 2026, with all four resolutions passed by requisite majority. Total shareholders on record as on the cut-off date of September 23, 2026 stood at 81,565; 120 members voted via remote e-voting. Resolution 1 (adoption of financial statements for FY ended March 31, 2026) passed with 99.9696% votes in favour. Resolution 3 (appointment of Dipankar Dasgupta as Independent Non-Executive Director) passed as a Special Resolution with 99.8706% votes in favour. Resolution 4 (ratification of remuneration of M/s. Sai Krishna & Associates for FY ending March 31, 2027) passed with 99.8730% votes in favour.
1mo agoGennex Laboratories submits FY26 annual report ahead of September AGM
Gennex Laboratories submitted its 41st Annual Report for FY26 to stock exchanges. The filing includes financial statements and the AGM notice per SEBI LODR Regulation 34. The annual general meeting is scheduled for September 30, 2026, via video conferencing. E-voting facility is provided by NSDL with a cut-off date of September 23, 2026.
2mo agoGennex Laboratories schedules board meeting for September 4
Board meeting scheduled for September 4, 2026. Agenda includes conduct of 41st AGM for FY26. Appointment of AGM scrutinizer to be considered. Intimation issued under SEBI LODR Regulation 29.
2mo agoGennex Laboratories Q1 Results: Revenue up 31%, net profit dips 4%
Gennex Laboratories posted a 31% YoY revenue jump to ₹36.67 crore in Q1FY27, but net profit slipped 4% to ₹3.96 crore due to margin compression. Consolidated revenue rose 15% to ₹41.85 crore, while consolidated net profit fell 7% to ₹4.67 crore. The Board approved the results on August 14, 2026.
2mo agoGennex Laboratories closes trading window from July 01, 2026
Gennex Laboratories Limited has closed its trading window from July 01, 2026, until 48 hours after the announcement of its unaudited Q1FY27 results. The move follows SEBI regulations to prevent insider trading. The board meeting date to approve the financial results will be announced later.
4mo agoGennex Laboratories promoter pledges shares for business loan
Premier Fiscal Services Private Limited, a promoter of Gennex Laboratories Limited, pledged 25,00,000 equity shares (1.029%) to Vidya Tradecon Private Limited on June 9, 2026, to secure a business loan of Rs. 1.25 crore. The pledge, expiring on December 7, 2026, provides a security cover ratio of 2.0 based on the pledged shares' value of Rs. 2.50 crore. Following this transaction, the promoter's total encumbered shares increased to 1,25,00,000, representing 5.145% of the total share capital.
5mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,896.40 | +0.60% | ₹4,55,009.88 | 41.20 | +9.49% | |
| ₹11,503.00 | +0.16% | ₹3,05,368.51 | 90.40 | +76.43% | |
| ₹4,686.00 | -0.87% | ₹1,78,240.38 | 85.50 | +22.52% | |
| ₹2,432.80 | +1.37% | ₹1,31,447.16 | 97.10 | +145.92% | |
| ₹1,204.50 | -0.12% | ₹1,20,149.34 | 28.00 | +26.60% | |
| ₹1,388.50 | +0.14% | ₹1,15,895.36 | 42.00 | +12.92% | |
| ₹1,408.80 | +0.04% | ₹1,13,811.10 | 39.90 | -7.27% | |
| ₹2,665.50 | +1.02% | ₹1,10,097.17 | 48.10 | +17.42% | |
| ₹1,814.80 | +0.42% | ₹1,04,419.58 | 26.00 | +53.33% | |
| ₹2,019.00 | +0.20% | ₹92,326.85 | 17.60 | -0.73% | |
| ₹2,641.50 | -0.69% | ₹74,549.65 | 51.60 | +42.95% | |
| ₹5,182.50 | -2.25% | ₹61,964.56 | 30.50 | -10.14% |
An investment of ₹10,000 made 5 years ago in Gennex Laboratories is now worth
₹ 12,962.00
Giving a profit of
₹ 2,962.00 (29.62%)
Note: Past profits do not guarantee future returns.